Anaptysbio (ANAB) EBIT Growth (1y) (2017 - 2026)
Anaptysbio (ANAB) EBIT Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 183.45% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -25.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.77% |
| Dec 31, 2025 | 791.84% |
| Sep 30, 2025 | 252.50% |
| Jun 30, 2025 | 35.10% |
| Mar 31, 2025 | 34.74% |
| Dec 31, 2024 | 77.05% |
| Sep 30, 2024 | 39.69% |
| Jun 30, 2024 | -0.44% |
| Mar 31, 2024 | 4.95% |
| Dec 31, 2023 | -62.23% |
| Sep 30, 2023 | -27.33% |
| Jun 30, 2023 | -44.40% |
| Mar 31, 2023 | -39.85% |
| Dec 31, 2022 | 16.64% |
| Sep 30, 2022 | -338.16% |
| Jun 30, 2022 | -5,115.57% |
| Mar 31, 2022 | -72.92% |
| Dec 31, 2021 | -193.44% |
| Sep 30, 2021 | 72.21% |
| Jun 30, 2021 | 97.65% |